Transplantation & Cellular Therapy Meetings 2022

The 2022 Transplantation & Cellular Therapy (TCT) Tandem Meetings from the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) offer the latest innovations, updates, and breakthroughs in cellular therapy research and care. Stay tuned for some of the studies being presented at this outstanding event.

CD34+ Graft Cell Dose in Allogeneic Peripheral Blood Stem Cell Transplantation

Citing that an optimal CD34+ graft cell dose (CD) for allogeneic peripheral blood stem cell transplant (allo-PBSCT) has not...

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil for GVHD Prevention

In an interim analysis presented by Najla El Jurdi, MD, at the Transplantation & Cellular Therapy 2022 Tandem Meetings,...

Minimum Residual Disease and Cytogenetic Persistence Prior to Hematopoietic Cell Transplant

In a poster featured at the Transplantation & Cellular Therapy 2022 Tandem Meetings, researchers examined outcomes in peripheral blood...

Hematology and Oncology News

Curated Journal Abstracts